Biden administration plans to reclassify marijuana, easing restrictions nationwide
Cannabis is currently classified along with drugs like heroin and LSD. The administration is expected to reschedule it in a category that includes steroids and Tylenol with codeine.
US poised to ease restrictions on marijuana in historic shift, but it’ll remain controlled substance
“Criminal records for marijuana use and possession have imposed needless barriers to employment, housing, and educational opportunities,” Biden said in December. “Too many lives have been upended because of our failed approach to marijuana. It’s time that we right these wrongs.”
The Health Hazards of Legalizing Marijuana
The rising numbers of adverse effects occurring in the wake of legislative reform of marijuana are disturbing. But they are not surprising.
The federal government is poised to loosen restrictions on marijuana. Here’s how that could impact Massachusetts.
The move could mark the largest federal cannabis policy change in decades, removing the drug from being classified as “Schedule I,” to a lower-risk category called “Schedule III.”
Potential negative effects of easing marijuana restrictions
As the Biden administration is set to ease federal marijuana restrictions, NBC News’ Tom Llamas spoke with Kevin Sabet, the President at Smart Approaches to Marijuana, on what he believes are the potential dangers of reclassifying the drug.
Biden poised to ease marijuana restrictions
President Joe Biden is reportedly on the cusp of approving a historic reclassification of cannabis from a Schedule I narcotic alongside heroin and other hard drugs to a much more permissive Schedule III drug.
Eased Cannabis Restrictions Are Coming to the U.S., What To Know
The U.S. Drug Enforcement Administration plans to reclassify marijuana from a Schedule I to a Schedule III drug. The move will not make cannabis legal for recreational use across the country, but will view the drug as less dangerous in the eyes of the law.
Marijuana restrictions could soon be eased in US | What it means for Georgia
Restrictions on marijuana could soon be eased more than ever before in the United States, which would mark a historic shift in how the drug is classified. The Biden Administration could soon reclassify marijuana as a Schedule III drug,
Justice Department recommends loosening marijuana restrictions
The Department of Justice proposed making cannabis a Schedule 3 drug, acknowledging after decades of illicit use that it has medical value and a lower risk for abuse. It’s currently Schedule 1, along with heroin.
DEA to ease restrictions on marijuana, reclassify it as low-risk substance, sources say
In a historic move that does not legalize adult-use marijuana nationwide but eases its restrictions, the U.S. Drug ...
Medscape2d
New FDA Orphan Drugs
FDA Approves Clobazam Add-On for Lennox Syndrome The benzodiazepine is already available in 100 other countries, marketed under different brand names. News, October 24, 2011 Orphan Drug Status for ...
Daily Mail1mon
FDA to axe ban that prevented gay and bisexual men from donating their sperm
The FDA is set to axe its ban on gay and bisexual men donating sperm, it has been revealed. Under the current rule, men who have had sex with men within the last five years are blocked from ...
The Washington Post9d
Agony over ecstasy: FDA bid shows it’s hard to test psychedelics
MDMA is the first of these to reach the doorstep of FDA approval, and leaders in the psychedelic medicine field say the agency’s decision could lay the groundwork for how the federal government ...
CBS News19d
FDA announces recall of heart pumps linked to deaths and injuries
A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA's most serious recall, the agency announced Monday. The recall comes years after surgeons say ...
High Times25d
U.K. Eases Restrictions on Hemp Agriculture
The government of the United Kingdom has approved changes to the rules governing industrial hemp licenses designed to make it easier for farmers to grow the crop. The new regulations will support ...
Cannabis stocks pull back after rallying on DEA’s plans to reclassify marijuana
Canopy Growth Corp., Tilray Brands Inc. and Curaleaf Holdings Inc. were among cannabis stocks that were sliding into the red ...
CBS News9d
Pasteurization working to kill bird flu in milk and other dairy products, FDA tests find
"In addition to preliminary results released late last week on an initial set of 96 retail milk samples, these results reaffirm our assessment that the commercial milk supply is safe," the FDA ...